stars 1 stars 2 stars 3

eGenomics has developed a predictive epidemiological system that uses rapid DNA sequencing and analytical computer software to track and predict the spread of bacteria, viruses and fungi in hospitals and other high-risk environments. The company was founded by Dr. Barry Kreiswirth and Steve Naidich as the result of their long-term collaboration studying DNA fingerprinting and nosocomial infections. Their research has been published recently in the prestigious journals "Proceedings of the National Academy or Sciences", "Nature Medicine", "The Journal of Infectious Diseases", and "The Journal of Clinical Microbiology", to name a few. Dr. Kreiswirth is a renowned infectious disease expert having pioneered the techniques of molecular fingerprinting with his research studying M. tuberculosis and S. aureus.

View Top Employees from eGenomics Inc

eGenomics Inc Questions

The eGenomics Inc annual revenue was $6 million in 2024.

eGenomics Inc is based in New York City, New York.

The NAICS codes for eGenomics Inc are [541714, 541, 5417, 54171, 54].

The SIC codes for eGenomics Inc are [873, 87].

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users